Michael G. Knell is Interim Chief Financial Officer, Corporate Senior Vice President, and Chief Accounting Officer of Charles River Laboratories. He joined the Company in April 2017 as Corporate Senior Vice President and Chief Accounting Officer. In this role, Mr. Knell is responsible for providing strategic guidance to the finance groups, including direction of the Global Accounting, Financial Planning and Analysis, and Tax functions; maintaining the Company's fiscal records; and preparing its financial reports. He also oversees the design and operation of the Company's system of internal controls, ensuring compliance with the rules and regulations of the Sarbanes-Oxley Act.
In October 2025, Mr. Knell was appointed by the Board to act as the Company's interim Chief Financial Officer, effective upon the September 2025 departure of Flavia H. Pease, serving as the Company's principal financial officer until a permanent successor is named. The Company subsequently announced the appointment of Glenn Coleman as Corporate Executive Vice President and Chief Financial Officer (with a tentative start date of April 6, 2026), after which Mr. Knell continues in his role as Corporate Senior Vice President and Chief Accounting Officer.
Prior to joining the Company, Mr. Knell served as the Chief Accounting Officer and Vice President of Finance at Bruker Corporation from 2012 to 2017. He was with Ernst & Young LLP in its Boston office from 1998 until 2011, where he served in various roles including Partner - Assurance Services. Mr. Knell is a Certified Public Accountant in Massachusetts and holds a B.S. degree in Business Administration from the State University of New York at Buffalo.